New Antiviral, Antibacterial and Antifungal Agents

Bacterial resistance is a growing threat and yet few new antibiotics active against multi-resistant bacteria are being explored. A combination of falling profits, regulatory mechanisms and irrational and injudicious use of antibiotics has led to an alarming situation where some infections have no cure. In this article, we summarize the new developments that have been suggested to incentivize the pharmaceutical industries toward the field of infections. We also briefly mention the new compounds on the horizon and some newly approved compounds that might help us tide over this crisis.

  • Mechanisms of action, preclinical data & pharmacology
  • Pharmacokinetics/pharmacodynamics
  • Clinical trials
  • Pharmacoepidemiology
  • New technologies in the development
  • Prescribing Improved agents
  • Advancement

Related Conference of New Antiviral, Antibacterial and Antifungal Agents

New Antiviral, Antibacterial and Antifungal Agents Conference Speakers